AbbVie today announced that the European Commission (EC) granted marketing authorization to RINVOQ® (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in adult patients.

Ronald Reagan says in the video that tariffs inevitably lead to retaliation by foreign countries and could trigger trade wars ...

Business owners who rent space at a historic landmark on East Sussex seafront said they were being forced out by plans to ...

A dramatic U.S. stock slide is fanning fears of even more dire scenarios for the market, as investors weigh the potential for ...

BSE Sensex and Nifty50, the Indian equity benchmark indices, rallied strongly in opening trade on Tuesday a day after the ...

If you're considering buying CDs to boost your savings goals, Fidelity CDs may be a smart option. Here's what to know about ...

New Zealand will not revise its economic and fiscal plans despite the turmoil in the global financial markets triggered by ...

Most Americans might be rightly focused on President Donald Trump’s trade war and the tariff drama that has devalued ...

Maria McCauley, Director of Libraries, Cambridge Public Library, Cambridge, Massachusetts, has been elected 2025-2026 ...

The U.S. Conference of Catholic Bishops announced Monday that it is ending its partnership with the federal government for ...

How did Kelvin Sampson become the Houston men's basketball coach? A look back at the NCAA sanctions that helped lead Sampson ...

Chelsea believe they will escape a points deduction or transfer ban as the Premier League investigates financial ...